Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-ALA Photopheresis in Crohn's Disease
NCT04164849Phase 2Completed
- Start
- Nov 2019
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 5-aminolevulinic acid in Crohn's disease. Started Nov 2019; status: completed.
02
Drugs
5-aminolevulinic acid
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT04164849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04164849.